GovChime
Notice ID: cc1568ad9b8c4131a7f61eb10c01eca8Special Notice

Scientific Support for Viral Diseases Branch (VDB) Research Projects

Archived. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:00 AM UTC−05:00
Posted
January 24, 2022
Notice type
Special Notice
NAICS
541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Agency
Department of WarDepartment of the Army

Notice details

Office
W4PZ USA MED RSCH ACQUIS ACT
Last updated
Dec 4, 2025

Identifiers

Solicitation number
W81XWH22R0020
Notice ID
cc1568ad9b8c4131a7f61eb10c01eca8

Description

The United States Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis, IAW 10 United States Code 2304(c)(1) as implemented in the Federal Acquisition Regulation 6.302-1(a)(2)(iii)(A), to State University of New York (SUNY)-Upstate Medical University (UMU), 750 E Adams Street, Syracuse NY 13210, as the only responsible source that can provide the Walter Reed Army Institute of Research (WRAIR) Viral Diseases Branch (VDB) research for single cell RNA sequencing (scRNAseq) pipeline and associated data analysis strategies to include the Alpha-Virus Vectored Antibody Delivery (AVVAD) platform.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:W81XWH22R0020
  1. Special NoticeCurrentJan 24, 2022

    Scientific Support for Viral Diseases Branch (VDB) Research Projects

    Notice cc1568ad9b8c4131a7f61eb10c01eca8 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
The United States Army Contracting Command-Detroit Arsenal on behalf of Project Manager Solider Survivability (PM SSV) intends to solicit on a sole source basis under the statutory authority permitting Other than Full and Open Competition 10 United States Code 3204(b)(B)(ii), as implemented by Federal Acquisition Regulation 6.302-1(a)(2)(iii)(B), Services may be deemed to be available only from the original source in the case of follow-on contract for the continued provision of highly specialized services when it is likely that award to any other source would result in unacceptable delays in fulfilling the agency’s requirements, to DCS Corporation, 6909 Metro Park Drive Suite 500, Alexandria Virginia 22310 for the procurement of four (4) months of Systems Engineering and Technical Assistance (SETA) Support Services. The procurement of the services will be executed via a modification to an existing award. This notice is not a request for proposals or quotations. Requests for copies of a solicitation in response to this notice will not be honored or acknowledged. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government. Interested parties may identify their capabilities by responding to this requirement, no later than 3:30 pm EST, 14 August 2026. All information submitted should support the offeror's capability to provide the services required, and shall be furnished at no cost or obligation to the Government. Responses must be in writing and must provide clear and concise documentation indicating an offeror's bona fide capability to provide these services. Verbal responses are not acceptable and will not be considered. Responses shall be submitted via email to lieselotte.h.pattee.civ@army.mil and theresa.s.quick.civ@army.mil.
-Special Notice11/27/2026
The Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), Medical - Accelerated Defense Pharmaceuticals program is formally requesting information from capable companies. The objective of the program is to progress the development of existing prophylactic MCMs manufactured on existing platform technologies that support clinical safety and/or possess strong preclinical immunogenicity, safety, and efficacy data.
-Special Notice11/18/2026
See attached Justification And Approval document.
-Sole Source / J&AOpen
W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generative Unconstrained Intelligence Drug Engineering (GUIDE) is an integrated computational and experimental platform designed to accelerate medical countermeasure development. GUIDE harnesses the power of advanced simulation and machine learning to enable preparedness and facilitate rapid response to protect the warfighter from a diverse and dynamic threat space. GUIDE impacts the discovery and design of biological products (e.g., monoclonal antibodies and vaccines) as well as small molecule drugs by simultaneously optimizing critical quality attributes of safety, efficacy, manufacturability and pharmacokinetics/pharmacodynamics while concurrently accounting for critical design attributes affecting developability and biophysical properties. GUIDE is a collaboration between U.S. interagency, academic and industry partners and is closely linked to the Accelerated Antibodies, Rapid Access to Products in Development (RAPID), Vaccine Acceleration by Modular Progression (VAMP), and Rapid Acquisition and Investigation of Drugs for Repurposing (RAIDR) programs. Additional information may be found at: https://armyeitaas.sharepoint-mil.us/sites/usaasc-jpeocbrnd The GUIDE Program will be carried out under the terms of a Participant Basic Agreement (PBA). The PBA is available for qualified entities interested in participating. Entities wishing to participate shall submit an email requesting participation to the Primary Point of Contact identified below demonstrating technical relevancy in development of Medical Countermeasures. Material that is only advertisement or marketing material in nature is not desired. Entities requesting participation will be reviewed by the program office to determine their technical relevance to the program, and subsequently invited to participate as a qualified entity. Projects awarded resulting from participation in the GUIDE Program may be awarded under authority 10 U.S.C. 4022 and 10 U.S.C. 4023. Agreements awarded pursuant to 10 U.S.C. 4022 and 10 U.S.C. 4023 will NOT be made or issued under the provisions of the Competition in Contracting Act of 1984 (P.L. 98-369), FAR Part 6 or any other FAR based regulation. The U.S. Army Contracting Command - Aberdeen Proving Ground (ACC-APG), Edgewood Contracting Division is supporting JPL EB in the execution of the GUIDE Program. Primary Point of Contacts: Joseph McCaffery Email Address: joseph.w.mccaffery2.civ@army.mil Keith Pereira Email Address: keith.d.pereira.civ@army.mil Please send technical and administrative questions and inquiries to the Primary Point of Contacts to facilitate communication on all matters relating to this Announcement. The Government is prohibited from soliciting and awarding actions to contractors that have engaged or are suspected to have engaged in criminal, fraudulent, or seriously improper conduct. Prospective vendors shall complete electronic annual representations and certifications at SAM. There is a requirement that prospective awardees MUST be registered in the System for Award Management (SAM) database prior to submitting an invoice and through final payment of any agreement resulting from any award. Vendors that are not registered should consider applying for registration immediately. To remain registered in the SAM database after the initial registration, the Vendors is required to review and update on an annual basis from the date of initial registration (or subsequent updates) its information in the SAM database to ensure it is current, accurate and complete. This notification is for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited.
-Special Notice10/18/2028
SEE AMENDMENT 0009 for updated Attachment 01. All changes are highlighted in Yellow.
-Special Notice10/31/2027

Additional Details

Solicitation Number

W81XWH22R0020

Archive Date

Not specified

Office Address

FORT DETRICK, MD, 21702-5014